Announcing Research Talks @cvsuor.bsky.social 🗓️October 8, 🏥K207; 🕒2:30-4PM @urochestersmd.bsky.social 1️⃣ Benjamin Chin @rittigers.bsky.social
2️⃣ Alex Kotelsky #BauschLomb 3️⃣ Raja Narayanan @flaumeye.bsky.social; #VisionScience #Optics #Ophthalmology; @uofrbme.bsky.social @urneuroscience.bsky.social

Bausch + Lomb board members resign after Icahn agreement ends (Reuters) -Bausch + Lomb said on Monday Brett Icahn and Gary Hu have resigned from its board of directors after the termination of the agreement with billionaire Carl Icahn and some of his affiliates. The agreement, dated June 21, 2022, ended after the Icahn group’s net long position in Bausch Health Companies (NYSE:BHC), Bausch + Lomb’s parent, fell below the required threshold. On Friday, Bausch Health said Paulson Capital (OTC:VBIVQ), along with certain affiliates and managed funds, increased their position in the company and acquired about 34.7 million common shares previously held by the Icahn Group. In April, Carl Icahn had built an economic interest covering about 34% of Bausch Health’s shares. With valuations skyrocketing in 2024, many investors are uneasy putting more money into stocks. Sure, there are always opportunities in the stock market – but finding them feels more difficult now than a year ago. Unsure where to invest next? One of the best ways to discover new high-potential opportunities is to look at the top performing portfolios this year. ProPicks AI offers 6 model portfolios from Investing.com which identify the best stocks for investors to buy right now. For example, ProPicks AI found 9 overlooked stocks that jumped over 25% this year alone. The new stocks that made the monthly cut could yield enormous returns in the coming years. Is BHC one of them?

Click Subscribe #BauschLomb #Icahn #CorporateNews #BoardResignation #BusinessUpdate

Howard G. Smith MD, AM on Instagram: "Bausch + Lomb enVista Aspire™, enVista Envy™, and enVista® Monofocal Intraocular Lenses Create Unacceptable Tissue Reactions These intraocular lenses are trigger... 0 likes, 0 comments - drhowardsmithreports on April 20, 2025: "Bausch + Lomb enVista Aspire™, enVista Envy™, and enVista® Monofocal Intraocular Lenses Create Unacceptable Tissue Reactions These intra...

Bausch + Lomb enVista Aspire™, enVista Envy™, and enVista® Monofocal Intraocular Lenses are triggering toxic anterior segment syndrome (TASS), an inflammatory reaction that occurs following cataract surgery. #bauschlomb #envista #intraocular #lens #toxic #recall
www.instagram.com/drhowardsmit...

Fitch upgrades Bausch + Lomb rating, maintains evolving watch Blog Mobile Portfolio Widgets About Us Advertise Help & Support Authors Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Click Subscribe #FitchRatings #BauschLomb #StockMarket #InvestmentNews #FinancialUpdates

Thrilled to be at the forefront of ophthalmology with the Bausch + Lomb ENVY IOL! This next-gen diffractive IOL delivers 4D of continuous vision—a leap beyond traditional trifocals.

Huge thanks to Bianca D. & Mela Bilyk for their support and early access! #BauschLomb #ENVYIOL

【公式】ボシュロム アクアロックス® on Instagram: "#平野紫耀 さんがボシュロムのイメージキャラクターに起用決定🎉👓✨ 引き続き#ボシュロム と一緒に、あなたの視界をサポートします👏✨ 詳細はプロフィールのURLからご覧ください！ #bauschlomb#aqualox#アクアロックス#滴るレンズ" 6,964 likes, 779 comments - aqualox_jp on February 28, 2024: "#平野紫耀 さんがボシュロムのイメージキャラクターに起用決定🎉👓✨..."

公式さんが動き出したね！！
#平野紫耀 #ShoHirano #Number_i
#bauschlomb #aqualox #アクアロックス #滴るレンズ

www.instagram.com/p/C39Ky7dSPn...